Attached files
| file | filename |
|---|---|
| 10-K - TG THERAPEUTICS, INC. | v179142_10k.htm |
| EX-4.9 - TG THERAPEUTICS, INC. | v179142_ex4-9.htm |
| EX-31.2 - TG THERAPEUTICS, INC. | v179142_ex31-2.htm |
| EX-23.1 - TG THERAPEUTICS, INC. | v179142_ex23-1.htm |
| EX-31.1 - TG THERAPEUTICS, INC. | v179142_ex31-1.htm |
| EX-4.10 - TG THERAPEUTICS, INC. | v179142_ex4-10.htm |
| EX-10.35 - TG THERAPEUTICS, INC. | v179142_ex10-35.htm |
| EX-10.37 - TG THERAPEUTICS, INC. | v179142_ex10-37.htm |
| EX-10.36 - TG THERAPEUTICS, INC. | v179142_ex10-36.htm |
Exhibit
32.1
CERTIFICATION
Pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, the undersigned officers of Manhattan
Pharmaceuticals, Inc. hereby certifies that, to the best of their
knowledge:
(a) the
Annual Report on Form 10-K of Manhattan Pharmaceuticals, Inc. for the year ended
December 31, 2009 the “Report”) fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934; and
(b) information
contained in the Report fairly presents, in all material respects, the financial
condition and results of operations of Manhattan Pharmaceuticals,
Inc.
|
Dated:
March 31, 2010
|
S:/
Michael McGuinness
|
|
|
Michael
G. McGuinness
|
||
|
Principal
Executive Officer,
|
||
|
Chief
Operating and Financial Officer
|